Article Text

Download PDFPDF
A single dose of azithromycin was more effective than ciprofloxacin for severe cholera in men in Bangladesh

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.


 
 Q Are single dose azithromycin and single dose ciprofloxacin equivalent for treatment of severe cholera in adults?

Clinical impact ratings Tropical & travel medicine ★★★★★★★ Infectious disease ★★★★★★☆ Endocrine ★★★★★★☆

METHODS

Embedded ImageDesign:

randomised controlled trial.

Embedded ImageAllocation:

{concealed*}.

Embedded ImageBlinding:

blinded {patients, healthcare providers, data collectors, outcome assessors, data analysts, and monitoring committee}.*

Embedded ImageFollow up period:

48 hours (for primary outcome).

Embedded ImageSetting:

a diarrhoea treatment centre in Dhaka, Bangladesh.

Embedded ImagePatients:

198 men 18–60 years of age (median age 25 y) who had watery diarrhoea for ⩽24 hours, severe dehydration, a high purging rate (stool volume ⩾20 ml/kg body weight over a 4 hour period after initial rehydration), and isolation of Vibrio cholerae O1 or O139 from a stool or rectal swab sample. Exclusion criteria were concomitant illness or receipt of an antimicrobial agent effective for treatment of cholera.

Embedded ImageIntervention:

azithromycin, two 500 mg tablets, plus a placebo formulation of ciprofloxacin …

View Full Text

Footnotes

  • * See glossary.

  • Information provided by author.

  • For correspondence: Dr D Saha, International Centre for Diarrhoeal Disease Research, Dhaka, Bangladesh. dsaha{at}icddrb.org

  • Sources of funding: Pfizer, National Institute of Allergy and Infectious Diseases; Wellcome Trust. Pfizer provided azithromycin tablets, and Square Pharmaceuticals provided ciprofloxacin tablets.

Linked Articles

  • Glossary
    BMJ Publishing Group Ltd